Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$24.0 million.

  • Molecular Partners Ag's Net Cash Flow fell 90674.08% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 10495.13%. This contributed to the annual value of -$4.9 million for FY2024, which is 10425.97% down from last year.
  • Latest data reveals that Molecular Partners Ag reported Net Cash Flow of -$24.0 million as of Q3 2025, which was down 90674.08% from $23.2 million recorded in Q2 2025.
  • Molecular Partners Ag's Net Cash Flow's 5-year high stood at $115.5 million during Q4 2023, with a 5-year trough of -$67.8 million in Q4 2021.
  • Moreover, its 5-year median value for Net Cash Flow was $300.17 (2024), whereas its average is $3.1 million.
  • Examining YoY changes over the last 5 years, Molecular Partners Ag's Net Cash Flow showed a top increase of 641449.33% in 2025 and a maximum decrease of 90674.08% in 2025.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Net Cash Flow stood at -$67.8 million in 2021, then skyrocketed by 124.3% to $16.5 million in 2022, then skyrocketed by 600.92% to $115.5 million in 2023, then plummeted by 104.28% to -$4.9 million in 2024, then plummeted by 385.62% to -$24.0 million in 2025.
  • Its Net Cash Flow stands at -$24.0 million for Q3 2025, versus $23.2 million for Q2 2025 and $19554.5 for Q1 2025.